CoChat

Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis

Open access

Published version of a preprint

The DOI matches its Crossref record; 73 of the 74 references it cites were found in a registry or an index.

Abstract

Maternal antibodies (MAbs) protect against infections in immunologically-immature neonates. Maternally transferred immunity may also be harnessed to target diseases associated with endogenous protein misfolding and aggregation, such as Alzheimer’s disease (AD) and AD-pathology in Down syndrome (DS). While familial early-onset AD (fEOAD) is associated with autosomal dominant mutations in the APP , PSEN1,2 genes, promoting cerebral Amyloid-β (Aβ) deposition, DS features a life-long overexpression of the APP and DYRK1A genes, leading to a cognitive decline mediated by Aβ overproduction and tau hyperphosphorylation. Although no prenatal screening for fEOAD-related mutations is in clinical practice, DS can be diagnosed in utero. We hypothesized that anti-Aβ MAbs might promote the removal of early Aβ accumulation in the central nervous system of human APP -expressing mice. To this end, a DNA-vaccine expressing Aβ 1-11 was delivered to wild-type female mice, followed by mating with 5xFAD males, which exhibit early Aβ plaque formation. MAbs reduce the offspring’s cortical Aβ levels 4 months after antibodies were undetectable, along with alleviating short-term memory deficits. MAbs elicit a long-term shift in microglial phenotype in a mechanism involving activation of the FcγR1/Syk/Cofilin pathway. These data suggest that maternal immunization can alleviate cognitive decline mediated by early Aβ deposition, as occurs in EOAD and DS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-021-01851-6

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Maternally induced anti-Aβ antibodies cross the placenta and lactation into the circulation of 5xFAD fetuses and newborns. a Study design for dams (upper timeline) and pups (bottom timeline). Serum anti-Aβ antibodies were measured in vaccinated dams (b–f), fetuses, and newborns (g–h). b Anti-Aβ IgG titer in AβCoreS (n = 12) and HBsAg (n = 10) vaccinated dams. c Anti-HBsAg IgG titer in AβCoreS and HBsAg vaccinated dams. d A negative correlation between anti-Aβ IgG and anti-HBsAg IgG in vaccinated dams. e Anti-Aβ Ig isotypes in AβCoreS and HBsAg vaccinated dams. f Anti-HBsAg Ig isotypes in AβCoreS and HBsAg vaccinated dams. g Maternally induced anti-Aβ Abs cross the placenta and lactation to the circulation of fetuses and newborns. h IgG2b is the most transferable isotype via the placenta and lactation. *P < 0.05, ****P < 0.0001, unpaired t-test, linear regression, Pearson’s correlation, one-way ANOVA, two-way ANOVA, repeated measures two-way ANOVA, data are presented as mean ± SEM.
Fig. 1 Maternally induced anti-Aβ antibodies cross the placenta and lactation into the circulation of 5xFAD fetuses and newborns. a Study design for dams (upper timeline) and pups (bottom timeline). Serum anti-Aβ antibodies were measured in vaccinated dams (b–f), fetuses, and newborns (g–h). b Anti-Aβ IgG titer in AβCoreS (n = 12) and HBsAg (n = 10) vaccinated dams. c Anti-HBsAg IgG titer in AβCoreS and HBsAg vaccinated dams. d A negative correlation between anti-Aβ IgG and anti-HBsAg IgG in vaccinated dams. e Anti-Aβ Ig isotypes in AβCoreS and HBsAg vaccinated dams. f Anti-HBsAg Ig isotypes in AβCoreS and HBsAg vaccinated dams. g Maternally induced anti-Aβ Abs cross the placenta and lactation to the circulation of fetuses and newborns. h IgG2b is the most transferable isotype via the placenta and lactation. *P < 0.05, ****P < 0.0001, unpaired t-test, linear regression, Pearson’s correlation, one-way ANOVA, two-way ANOVA, repeated measures two-way ANOVA, data are presented as mean ± SEM.CC BY · PubMed Central
Fig. 2 Active immunization induced high anti-Aβ antibody production in maternally vaccinated 5xFAD mice. Serum anti-Aβ antibodies were measured in the offspring following maternal vaccination at 1 m of age (a–c) as well as following active vaccination (d–j). a Antibody titer was measured in the serum of maternally vaccinated and control 1m-old mice. b Ig isotypes in the serum of 1m-old offspring, normalized to mothers’ titer before pregnancy. c Offspring IgG2b is positively correlated with maternal IgG2b prior to pregnancy. Maternally and sham-vaccinated mice were actively vaccinated at 1 m of age against Aβ (n = 5). Antibody titer was measured at 2.5, 3.5, and 5 m. d log10OD of total IgG concentration in the serum. Serum levels of (e) IgG1, (f) IgG3, (g) IgG2a, (h) IgG2b, and (i) IgM. j Color-coded heat maps of IgG isotypes in vaccinated dams prior to mating (left panel), isotypes in maternally vaccinated offspring at 1 m of age, and following active vaccination at 2.5, 3.5, and 5 m of age. **P < 0.01, ***P < 0.001, ****P < 0.0001, linear regression, Pearson’s correlation, one-way ANOVA, two-way ANOVA, repeated measures two-way ANOVA, data are presented as mean ± SEM.
Fig. 2 Active immunization induced high anti-Aβ antibody production in maternally vaccinated 5xFAD mice. Serum anti-Aβ antibodies were measured in the offspring following maternal vaccination at 1 m of age (a–c) as well as following active vaccination (d–j). a Antibody titer was measured in the serum of maternally vaccinated and control 1m-old mice. b Ig isotypes in the serum of 1m-old offspring, normalized to mothers’ titer before pregnancy. c Offspring IgG2b is positively correlated with maternal IgG2b prior to pregnancy. Maternally and sham-vaccinated mice were actively vaccinated at 1 m of age against Aβ (n = 5). Antibody titer was measured at 2.5, 3.5, and 5 m. d log10OD of total IgG concentration in the serum. Serum levels of (e) IgG1, (f) IgG3, (g) IgG2a, (h) IgG2b, and (i) IgM. j Color-coded heat maps of IgG isotypes in vaccinated dams prior to mating (left panel), isotypes in maternally vaccinated offspring at 1 m of age, and following active vaccination at 2.5, 3.5, and 5 m of age. **P < 0.01, ***P < 0.001, ****P < 0.0001, linear regression, Pearson’s correlation, one-way ANOVA, two-way ANOVA, repeated measures two-way ANOVA, data are presented as mean ± SEM.CC BY · PubMed Central
Fig. 3 Combination of maternal and active vaccination rescues short-term memory abilities and normalizes exploratory behavior. A behavioral battery was conducted at 4 m of age (n = 5) to assess the effect of maternal and active vaccinations on cognition. a1 Short-term memory was assessed using the NOR test. a2 Occupancy plots of NOR arena—F (familiar object), N (novel object). b Total time near objects in the NOR test. c1 Exploratory behavior in the OF test. c2 Occupancy plots of the OF arena. d1 Anxiety-related behavior in the EZM. d2 Occupancy plots of the EZM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, two-way ANOVA, repeated measures two-way ANOVA, data are presented as mean ± SEM.
Fig. 3 Combination of maternal and active vaccination rescues short-term memory abilities and normalizes exploratory behavior. A behavioral battery was conducted at 4 m of age (n = 5) to assess the effect of maternal and active vaccinations on cognition. a1 Short-term memory was assessed using the NOR test. a2 Occupancy plots of NOR arena—F (familiar object), N (novel object). b Total time near objects in the NOR test. c1 Exploratory behavior in the OF test. c2 Occupancy plots of the OF arena. d1 Anxiety-related behavior in the EZM. d2 Occupancy plots of the EZM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, two-way ANOVA, repeated measures two-way ANOVA, data are presented as mean ± SEM.CC BY · PubMed Central
Fig. 4 Maternal vaccination reduces Aβ pathology independently of anti-Aβ antibody presence at adulthood. Cortical Aβ levels were measured using sELISA (a) TBST, (b) SDS, and (c) formic-acid soluble Aβ42 (n = 5). (d) TBST, (e) SDS, and (f) formic-acid soluble levels of cortical Aβ40 (n = 5). g Cortical Aβ42/40 ratio. h Insoluble Aβ levels at 5 m of age negatively correlate with IgG2b and IgM levels, following maternal vaccination. i Plaque load was quantified using immunofluorescence and blob detection. Plaques were pseudocolored in high magnification images to better separate and emphasize the different plaques. j Quantification of plaque density (plaques/mm2) and (k) Plaque tissue coverage (percentage), *P < 0.05, **P < 0.01, ****P < 0.0001, #P < 0.05, ##P < 0.01 compared to WT controls, two-way ANOVA, one-way ANOVA, Pearson’s correlation, data are presented as mean ± SEM.
Fig. 4 Maternal vaccination reduces Aβ pathology independently of anti-Aβ antibody presence at adulthood. Cortical Aβ levels were measured using sELISA (a) TBST, (b) SDS, and (c) formic-acid soluble Aβ42 (n = 5). (d) TBST, (e) SDS, and (f) formic-acid soluble levels of cortical Aβ40 (n = 5). g Cortical Aβ42/40 ratio. h Insoluble Aβ levels at 5 m of age negatively correlate with IgG2b and IgM levels, following maternal vaccination. i Plaque load was quantified using immunofluorescence and blob detection. Plaques were pseudocolored in high magnification images to better separate and emphasize the different plaques. j Quantification of plaque density (plaques/mm2) and (k) Plaque tissue coverage (percentage), *P < 0.05, **P < 0.01, ****P < 0.0001, #P < 0.05, ##P < 0.01 compared to WT controls, two-way ANOVA, one-way ANOVA, Pearson’s correlation, data are presented as mean ± SEM.CC BY · PubMed Central
Fig. 5 Maternal vaccination induces long-term FcRs upregulation in the brain. Levels of cerebral FcR mRNA were quantified using RT-qPCR after maternal vaccination at 1 m of age (a–e) and following maternal and active vaccination at 5 m of age (f–j). mRNA levels of (a) FcγRI, (b) FcγRIII, (c) FcγRIV, (d) FcRn, and (e) FcγRIIb in 1m-old WT (n = 14) and 5xFAD (n = 11) mice. Levels of (f) FcγRI, (g) FcγRIII, (h) FcγRIV, (i) FcRn, and (j) FcγRIIb in maternally and actively vaccinated 5m-old 5xFAD mice (n = 5). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, two-way ANOVA, data are presented as mean ± SEM.
Fig. 5 Maternal vaccination induces long-term FcRs upregulation in the brain. Levels of cerebral FcR mRNA were quantified using RT-qPCR after maternal vaccination at 1 m of age (a–e) and following maternal and active vaccination at 5 m of age (f–j). mRNA levels of (a) FcγRI, (b) FcγRIII, (c) FcγRIV, (d) FcRn, and (e) FcγRIIb in 1m-old WT (n = 14) and 5xFAD (n = 11) mice. Levels of (f) FcγRI, (g) FcγRIII, (h) FcγRIV, (i) FcRn, and (j) FcγRIIb in maternally and actively vaccinated 5m-old 5xFAD mice (n = 5). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, two-way ANOVA, data are presented as mean ± SEM.CC BY · PubMed Central
Fig. 6 Maternal vaccination upregulates microglial FcRs expression. Microglial FcγRI protein expression was quantified using immunofluorescence following maternal and active vaccination at 5 m of age (n = 5). a FcγRI expression was assessed using double-labeled immunofluorescence in Iba1+ microglia, using the x10 and x63 objectives for visualizing and quantification, respectively. b Quantification of FcγRI signal intensity among microglia. c Scatter plot and intensity distribution FcγRI signals in Iba1+ cells. d Overlay and comparisons of FcγRI expression distribution. *P < 0.05, **P < 0.01, ****P < 0.0001, two-way ANOVA, corrected two-sample Kolmogorov–Smirnov test, data are presented as mean ± SEM.
Fig. 6 Maternal vaccination upregulates microglial FcRs expression. Microglial FcγRI protein expression was quantified using immunofluorescence following maternal and active vaccination at 5 m of age (n = 5). a FcγRI expression was assessed using double-labeled immunofluorescence in Iba1+ microglia, using the x10 and x63 objectives for visualizing and quantification, respectively. b Quantification of FcγRI signal intensity among microglia. c Scatter plot and intensity distribution FcγRI signals in Iba1+ cells. d Overlay and comparisons of FcγRI expression distribution. *P < 0.05, **P < 0.01, ****P < 0.0001, two-way ANOVA, corrected two-sample Kolmogorov–Smirnov test, data are presented as mean ± SEM.CC BY · PubMed Central
Fig. 7 Maternal vaccination activates actin-cytoskeleton regulation pathways via Syk, AKT, ERK, and Cofilin phosphorylation. Level of Syk and downstream signaling molecules from the Fc-mediated phagocytosis pathway were measured using immunoblotting following maternal and active vaccination at 5 m of age (n = 5). Levels of (a, b) pSyk/Syk, (a, c) pAKT/AKT, (a, d) pERK/ERK, (a, e) pCofilin/Cofilin, and (a, f) Actin levels, normalized to tubulin. g Maternal and active vaccinations activate FcγR-mediated phagocytosis pathways through actin cytoskeleton regulation. *P < 0.05, **P < 0.01, two-way ANOVA, data are presented as mean ± SEM.
Fig. 7 Maternal vaccination activates actin-cytoskeleton regulation pathways via Syk, AKT, ERK, and Cofilin phosphorylation. Level of Syk and downstream signaling molecules from the Fc-mediated phagocytosis pathway were measured using immunoblotting following maternal and active vaccination at 5 m of age (n = 5). Levels of (a, b) pSyk/Syk, (a, c) pAKT/AKT, (a, d) pERK/ERK, (a, e) pCofilin/Cofilin, and (a, f) Actin levels, normalized to tubulin. g Maternal and active vaccinations activate FcγR-mediated phagocytosis pathways through actin cytoskeleton regulation. *P < 0.05, **P < 0.01, two-way ANOVA, data are presented as mean ± SEM.CC BY · PubMed Central
Fig. 8 Maternal vaccination enhances microglial phagocytosis. Microglia reactivity in the hippocampus was assessed using double labeling of CD68 and Iba1+ microglia following maternal and active vaccination at 5 m of age (n = 5). a Double labeling of CD68 and Iba1+ microglia using the x10 and x63 objectives for visualizing and quantification, respectively. b Quantification of CD68 signal intensity, lines represent the median and the 25, 75 percentiles. c CD68 mRNA levels were measured using RT-qPCR. *P < 0.05, ***P < 0.001, ****P < 0.0001, two-way ANOVA, data are presented as mean ± SEM.
Fig. 8 Maternal vaccination enhances microglial phagocytosis. Microglia reactivity in the hippocampus was assessed using double labeling of CD68 and Iba1+ microglia following maternal and active vaccination at 5 m of age (n = 5). a Double labeling of CD68 and Iba1+ microglia using the x10 and x63 objectives for visualizing and quantification, respectively. b Quantification of CD68 signal intensity, lines represent the median and the 25, 75 percentiles. c CD68 mRNA levels were measured using RT-qPCR. *P < 0.05, ***P < 0.001, ****P < 0.0001, two-way ANOVA, data are presented as mean ± SEM.CC BY · PubMed Central
Fig. 9 Maternal antibodies mediate Aβ phagocytosis by N9 microglial cell-line in a Syk-dependent manner. Phagocytosis capacity and intracellular signaling were assessed in N9 murine embryonic cell-line following treatment with either Aβ42 alone or Aβ42 pre-incubated with serum from anti-Aβ or sham-vaccinated dams. The contribution of Syk signaling was assessed using Syk inhibition by BAY-61-3606. a BAY inhibits Syk phosphorylation in a dose-dependent manner. b–d Phagocytosis of FBS-coated fluorescent beads by N9 cells is reduced following treatment with Syk inhibitor. e, f IF of N9 cells following incubation with Aβ reveals a reduction in phagocytosis capacity after Syk inhibition. g–j Serum from anti-Aβ vaccinated dams increases phagocytosis by N9 cells compared with serum from sham-vaccinated dams and abrogation of this effect following Syk inhibition. k Treatment with Aβ, serum from anti-Aβ or sham-vaccinated dams, or combined treatment reveals differences in the time-course of Syk phosphorylation. ***P < 0.001, ****P < 0.0001, unpaired t-test, Chi-squared test for independence, Fisher’s exact test, one-way ANOVA, data are presented as mean ± SEM.
Fig. 9 Maternal antibodies mediate Aβ phagocytosis by N9 microglial cell-line in a Syk-dependent manner. Phagocytosis capacity and intracellular signaling were assessed in N9 murine embryonic cell-line following treatment with either Aβ42 alone or Aβ42 pre-incubated with serum from anti-Aβ or sham-vaccinated dams. The contribution of Syk signaling was assessed using Syk inhibition by BAY-61-3606. a BAY inhibits Syk phosphorylation in a dose-dependent manner. b–d Phagocytosis of FBS-coated fluorescent beads by N9 cells is reduced following treatment with Syk inhibitor. e, f IF of N9 cells following incubation with Aβ reveals a reduction in phagocytosis capacity after Syk inhibition. g–j Serum from anti-Aβ vaccinated dams increases phagocytosis by N9 cells compared with serum from sham-vaccinated dams and abrogation of this effect following Syk inhibition. k Treatment with Aβ, serum from anti-Aβ or sham-vaccinated dams, or combined treatment reveals differences in the time-course of Syk phosphorylation. ***P < 0.001, ****P < 0.0001, unpaired t-test, Chi-squared test for independence, Fisher’s exact test, one-way ANOVA, data are presented as mean ± SEM.CC BY · PubMed Central
Fig. 10 Maternal antibodies mediate Aβ phagocytosis by primary adult microglia in a Syk-dependent manner. Aβ phagocytosis capacity of adult primary microglia was assessed following treatment with either Aβ42 alone or Aβ42 pre-incubated with serum from anti-Aβ or sham-vaccinated dams. The contribution of Syk signaling was assessed using Syk inhibition by BAY-61-3606. a Immunofluorescence images and (b) quantification of Aβ phagocytosis by adult primary microglia reveal that serum from anti-Aβ vaccinated dams facilitates Aβ clearance in a Syk-dependent pathway. **P < 0.01, ***P < 0.001, Chi-squared test for independence, Fisher’s exact test, data are presented as mean ± SEM.
Fig. 10 Maternal antibodies mediate Aβ phagocytosis by primary adult microglia in a Syk-dependent manner. Aβ phagocytosis capacity of adult primary microglia was assessed following treatment with either Aβ42 alone or Aβ42 pre-incubated with serum from anti-Aβ or sham-vaccinated dams. The contribution of Syk signaling was assessed using Syk inhibition by BAY-61-3606. a Immunofluorescence images and (b) quantification of Aβ phagocytosis by adult primary microglia reveal that serum from anti-Aβ vaccinated dams facilitates Aβ clearance in a Syk-dependent pathway. **P < 0.01, ***P < 0.001, Chi-squared test for independence, Fisher’s exact test, data are presented as mean ± SEM.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Cited by

See all 21

Metadata

Authors
Illouz, T., Nicola, R., Ben-Shushan, L., Madar, R., Biragyn, A., & Okun, E.
Affiliations
  • Bar-Ilan University (IL)
  • National Institute on Aging (US)
Corresponding author
Okun, Eitan
Venue
Communications Biology
Published
2021-03-12
Volume
4
Issue
1
Pages
329-329
ISSN
2399-3642 (ISSN-L)
OpenAlex
W3134089639
Cited by
21
References
74
Citations by year
2026: 3 · 2025: 3 · 2024: 1 · 2023: 11 · 2022: 1 · 2021: 2
FWCI
1.40
Type
journal article
Language
en
Open access
Licence
Locations
  • Communications Biology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • OSF Preprints (OSF Preprints) (submittedVersion)
Funders
  • Clore Israel Foundation
  • National Institute on Aging
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
maternal antibodies, amyloid-beta clearance, Fc gamma receptor, Syk, phagocytosis, maternal immunization, Alzheimer's disease, Down syndrome, APP overexpression, microglial phenotype, cofilin, DNA vaccine, 5xFAD mice, memory impairment
MeSH terms
Syk Kinase, Alzheimer Disease, Animals, Antibodies, Behavior, Animal, Brain, Cognition, Disease Models, Animal, Female, Immunization, Male, Memory, Mice, Inbred C57BL, Mice, Transgenic, Peptide Fragments, Phagocytosis, Phenotype, Signal Transduction, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Receptors, IgG, Microglia, Vaccines, DNA, Alzheimer Vaccines, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis. https://app.cochat.ai/papers/10.1038/s42003-021-01851-6
The paper
Illouz, T., Nicola, R., Ben-Shushan, L., Madar, R., Biragyn, A., & Okun, E. (2021). Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis. Communications Biology. https://doi.org/10.1038/s42003-021-01851-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.